GERD Study
Are you struggling with episodic heartburn due to symptomatic non-erosive gastroesophageal reflux disease (GERD)? You may be eligible to participate in an exciting clinical trial exploring new treatment options. By joining this study, you will have access to trial medications and comprehensive medical care at no cost to you. Additionally, participants may receive compensation for their time and travel. This is an opportunity to explore innovative therapies that could potentially provide effective relief from your heartburn symptoms while contributing to advancements in medical science. Take the first step toward a better quality of life today!
*Volunteers will receive study-related care, including the cost of the issued study drug, at no cost. Participants may receive compensation for their time and travel.
Get Started
This is a Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Subjects with Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 12 Weeks and to Evaluate the Safety and Usage of Vonoprazan 10 mg and Placebo As Needed for Relief of Episodic Heartburn Through 6 Months of Treatment
See If You Qualify For Our GERD Study!
- Must be 20 years of age
- Have been diagnosis of GERD or NERD
- Experience recurring acid reflux symptoms 2 or more days a week
*As a GERD or NERD research study participant, all study-related care will be provided at no cost to you, including the study drug. Participants may receive compensation for their time and travel.
More Research Studies Coming Soon
Screening for Colon Cancer
IBS-C
GERD
Menstrual Migraines
Diabetic Glucometer Device Study
(open to ALL ethnicities)
We will have more studies available. Click below to join the waiting list.
St. Charles Clinical Research
6034 Weldon Spring Parkway
Weldon Spring, Mo. 63304
General Inquiries
Pharmaceutical Study Experience
Abbott
Pfizer
SKK
SERES
Boston Scientific
Allergan
Merck
Biohaven
Techfield
Baxter
Furiex
Salix Pharmaceuticals
Covance
Cubist
Eli Lilly
GlaxoSmithKline
Galen
Iroko
Ironwood
Medicago
Medimmune
Novartis
Novavax
Noven Therapeutics
Seqirus USA
Teva USA
Vanda pharmaceuticals